Breaking Ground in Cancer Research: Introducing the Fanconi Cancer Foundation-AACR NextGen Grant

At the Fanconi Cancer Foundation, we’re dedicated to driving innovative research initiatives to find better treatments for people with FA as fast as possible. That’s why we’re thrilled to announce the launch of the Fanconi Cancer Foundation-AACR NextGen Grant for Transformative Cancer Research, a flagship funding opportunity in partnership with the American Association for Cancer Research (AACR).

This groundbreaking grant is designed to empower young investigators to pursue highly innovative research projects that may not fit within traditional funding channels. By promoting and supporting creative, paradigm-shifting cancer research, we aim to catalyze significant scientific discoveries and help talented researchers gain scientific independence.

Understanding Fanconi Anemia (FA) and Cancer

Fanconi anemia (FA) is a rare genetic disease caused by mutations in FA genes, integral to the FA/BRCA DNA repair pathway. Individuals with FA face a heightened risk of developing various cancers, including squamous cell cancers of the head and neck, esophagus, and anogenital regions, along with an elevated risk for other solid tumors.

Advancements in stem cell transplants have transformed FA from a childhood disease characterized by bone marrow failure to a recognized cancer predisposition syndrome. However, treating tumors in individuals with FA poses unique challenges due to underlying defects in the FA/BRCA DNA repair pathway.

Fostering Innovation and Collaboration

Through this grant, we seek to deepen our understanding of the FA/BRCA DNA repair pathway and its link to FA-associated cancers. By supporting research in this area, we aim to inform the development of novel diagnostics, preventive strategies, and therapies for individuals with FA and beyond.

Opportunities for Researchers

Applications are invited from researchers currently working in the FA field, as well as investigators with experience in other areas of cancer or biomedical research with an interest in studying FA-associated cancers. The grant provides $450,000 over three years to cover various research expenses, from salary and benefits to laboratory supplies and travel.

Apply Now

Are you ready to make a difference in cancer research?

Visit here to learn more about eligibility requirements, application details, and more.

Categories: Announcements, Research

Previous ArticleNext Article
Join us at the upcoming #FCFSymposium and FA Adult Retreat September 19- 22 in Charlotte, North Carolina.
This is default text for notification bar